43 results on '"Maiero S"'
Search Results
2. BOC.02.9: LOSS OF MULTIMERIN-2 IN COLORECTAL CANCER ASSOCIATES WITH VASCULAR INSTABILITYANDALTERED IMMUNE RESPONSE.
3. V.01.7: A LAPAROSCOPIC AND ENDOSCOPIC COOPERATIVE SURGERY (LECS) APPROACH FOR TREATMENT OF APPENDICEAL LESION IN PATIENTS WITH SERRATED POLYPOSIS SYNDROME (SPS).
4. T.09.7: PREDICTIVE VALUE OF COMBINED RISK SCORE FOR GASTRIC CANCER.
5. OC.18.6: MULTIMERIN-2 LOSS FAVORS COLORECTAL CANCER CELLS DISSEMINATION.
6. H. PYLORI INFECTION AFFECTS THE HER2-CDH1 INTERACTION.
7. OC.01.7: AN EMILIN1-ALTERED MICROENVIRONMENT PROMOTES TUMORCELL PROLIFERATIONAND LYMPHATIC DYSFUNCTION IN GASTRIC CANCER.
8. OC.13.4 THE ECM MOLECULE EMILIN-2 AFFECTS THE INFLAMMATORY RESPONSE VIA THE TLR-4/MYD88 PATHWAY IMPACTING ON COLORECTAL CANCER PATIENTS' PROGNOSIS.
9. AF.120 PCLE DETECTS MUCOSAL NEOPLASTIC VASCULAR PATTERN IN GASTRIC LINITIS PLASTICA.
10. AF.119 DISTINCTIVE VASCULAR PATTERNS HIGHLIGHTED BY PCLE IN GASTRIC DISEASES WITH HIGH RISK OF MALIGNANT COMPLICATIONS.
11. AF.72 MICROENCAPSULATED SODIUM BUTYRATE IN THE PREVENTION OF ACUTE RADIOTHERAPY PROCTITIS: SINGLE-CENTER PROSPECTIVE OBSERVATIONAL STUDY.
12. OC.05.4 PRECANCEROUS CONDITIONS AS RISK FACTOR FOR GASTRIC CANCER IN LYNCH SYNDROME.
13. P.01.13 METABOLOMICS AS COMPLEMENTARY OMIC APPROACH TO IMPLEMENT RISK CRITERIA FOR FIRST-DEGREE RELATIVES OF GASTRIC CANCER PATIENTS.
14. P.01.15 IS IT POSSIBLE TO PREDICT THE PRESENCE GASTRIC CARCINOIDS IN AUTOIMMUNE ATROPHIC CHRONIC GASTRITIS PATIENTS?
15. P.08.2: Autoimmune Atrophic Gastritis is Associated with Other Autoimmune Diseases.
16. P.08.10: Interference of PG2 Tata Box Region with the Serum PG2 Level in Gastric Cancer.
17. P.08.1: Endoscopic Follow up can Predict Genetic Involvement in Attenuated Adenomatous Polyposis with no APC Or MUTYH Identified Mutations.
18. OC.04.2 GENETIC DIVERSITY OF THE KIR/HLA SYSTEM AND OUTCOME OF PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY.
19. P.09.7 PROGNOSTIC SIGNIFICANCE OF CLINICALLY METASTATIC MESORECTAL LYMPH NODES IN LOCALLY ADVANCED RECTAL CANCER TREATED BY NEOADJUVANT CHEMORADIATION: IMPLICATIONS FOR SURGICAL STRATEGIES IN RELATION TO PATHOLOGICAL RESPONSE.
20. OC.04.7 IDENTIFICATION OF PROTEOMIC PROFILES ASSOCIATED WITH TUMOR REGRESSION GRADING IN RECTAL CANCER.
21. OC.10.2 POST PROCEDURAL COMPLICATIONS RELATED TO DECOMPRESSIVE PERCUTANEUS ENDOSCOPIC GASTROSTOMY IN ADVANCED CANCER PATIENTS WITH PREVIOUS ABDOMINAL SURGERY.
22. OC.13.1 IN VITRO CHARACTERIZATION OF CDH1 VARIANTS FIRST BY IMMORTALIZATION OF PERIPHERAL B-CELLS OF PATIENTS.
23. P.16.6 AMINOPYRINE BREATH TEST AS A DIAGNOSTIC TOOL TO EVALUATE HEPATIC FUNCTIONAL RESERVE IN NEOPLASTIC PATIENTS RECEIVING HIGH DOSE CHEMOTHERAPY.
24. P.17.10 EVALUATION OF CEA-IGM COMPLEXES IN THE DETECTION OF COLORECTAL CANCER.
25. P.08.5 IDENTIFICATION OF CDH1 GERMLINE MUTATIONS IN SPORADIC GASTRIC CANCER PATIENTS AND SUBJECTS AT RISK TO DEVELOP GASTRIC CANCER.
26. P.08.11 EXOCRINE-ENDOCRINE MODULATION IN COMMON GASTRIC CARCINOMAS.
27. OC.01.6 PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY: IN VIVO ANALYSIS OF ANGIOGENESIS AS A NEW BASIS FOR A TRANSLATIONAL APPROACH FOR COLO-RECTAL AND GASTRIC CANCERS.
28. OC.02.4 DIFFERENT PROTEIN EXPRESSION AND GENES PATTERNS OF HELICOBATER PYLORI IN PATHOLOGICAL DISORDERS OF THE GASTRIC MUCOSA.
29. OC.01.5: WHAT FACTORS AFFECT THE QUALITY OF BOWEL PREPARATION FOR COLONOSCOPY? A MULTICENTER PROSPECTIVE COHORT STUDY.
30. P.1.351: SERRATED ADENOMAS OF THE COLORECTUM: PREVALENCE IN ROUTINARY ENDOSCOPY PRACTICE.
31. P.1.65: KIR AND HLA COMBINATIONS IN AUTOIMMUNE GASTRITIS AND GASTRIC CANCER SUSCEPTIBILITY.
32. P.1.122: AUTOIMMUNE CHRONIC ATROPHIC GASTRITIS AND HELICOBACTER PYLORI: PREVALENCE OF THE INFECTION AND GENETIC HETEROGENEITY.
33. P.105 AN UNUSUAL CASE OF PNEUMATOSIS CYSTOIDES GASTRO-INTESTINALIS CAUSED BY NON-HODGKIN LYMPHOMA.
34. P.40 KIR/HLA GENOTYPE ASSOCIATED WITH COMPLICATED CELIAC DISEASE.
35. OC.06.2 CDH1 ANALYSIS AS A POSSIBLE MARKER FOR EARLY GASTRIC CANCER IN FIRST DEGREE GC-RELATIVES.
36. ANALYSIS OF MTHFR 677T SEGREGATION IN GASTRIC CANCER AND IN SUBJECTS WITH A FAMILY HISTORY OF GASTRIC CANCER.
37. PA.46 B*08-CW*07 PREDISPOSING FOR ADULT CELIAC DISEASE.
38. PA.40 IDENTIFICATION OF A NEW HLA-A*680102 VARIANT, ASSOCIATED WITH ANCESTRAL HAPLOTYPE B8-DR3 FROM TWO ITALIAN PATIENTS FROM FRIULI WITH CELIAC DISEASE.
39. OC3.05.3 BLOOD DONATION AND IRON DEFICIENCY: ANOTHER POSSIBLE FACE OF CELIAC DISEASE.
40. OC1.01.1 PPAR SIGNALLING PATHWAY IS INVOLVED IN CD-ASSOCIATED INFLAMMATION.
41. P-323 - Is FNA always necessary in submucosal lesion miming GIST?
42. Technical Note: Direct Enzyme Immunoassay of Progesterone in Bovine Milk Whey.
43. P-293 - Evaluation of neoangiogenesis in locally advanced gastric cancer before and after neoadjuvant radiochemotherapy by probe confocal laser endomicroscopy (PCLE).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.